Skip to main content

Table 1 Demographic and imaging characteristics of patients in groups A and B

From: Transarterial chemoembolisation in patients with hepatocellular carcinoma: low-dose doxorubicin reduces post-embolisation syndrome without affecting survival—prospective interventional study

  Group A (n = 15) Group B (n = 13) Statistical test p value
Age (years)
 Mean ± standard deviation 60.8 ± 6.4 56.6 ± 6.8 t = 1.674 0.106
 Median (minimum–maximum) 60 (53–74) 55 (44–66)
Gender
 Male 12 (80%) 12 (92.3%) χ2 = 0.862 0.600 (FE)
 Female 3 (20%) 1 (7.7%)
Number of TACE procedures
 1 1 (6.7%) 0 (0%) χ2 = 1.202 0.842 (MC)
 2 8 (53.3%) 6 (46.2%)
 3 6 (40%) 7 (53.8%)
Number of lesions per patient
 1 6 (40%) 4 (30.8%) χ2 = 0.776 0.871 (MC)
 2 8 (53.3%) 7 (53.8%)
 3 1 (6.7%) 2 (15.4%)
Pattern of masses in CT/MRI
 Irregular 8 (53.3%) 5 (38.5%) χ2 = 0.619 0.431
 Well-defined 7 (46.7%) 8 (61.5%)
Size of masses in cm
 Mean ± standard deviation 7.4 ± 2.2 6.7 ± 2.1 t = 0.854 0.401
 Median (minimum–maximum) 7 (4–11) 7 (3–11)
  1. FE Fisher exact, MC Monte Carlo, t Student t test, p p value for comparing between the studied groups